NasdaqGM - Delayed Quote USD
Supernus Pharmaceuticals, Inc. (SUPN)
32.28
+0.12
+(0.39%)
At close: 4:00:01 PM EDT
32.28
0.00
(0.00%)
After hours: 4:05:11 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 243,205 | 23 |
| Sales | 35,172 | 4 |
| Net Shares Purchased (Sold) | 208,033 | 27 |
| Total Insider Shares Held | 2.73M | -- |
| % Net Shares Purchased (Sold) | 8.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KHATTAR JACK A Chief Executive Officer | -- | Direct | -- | Mar 10, 2025 |
| DEC TIMOTHY C Chief Financial Officer | -- | Direct | -- | Mar 10, 2025 |
| MOTTOLA FRANK Officer | -- | Direct | -- | Mar 7, 2025 |
| KHATTAR JACK A Chief Executive Officer | -- | Direct | -- | Mar 7, 2025 |
| MOTTOLA FRANK Officer | -- | Direct | -- | Feb 26, 2025 |
| BHATT PADMANABH P Officer | -- | Direct | -- | Feb 21, 2025 |
| MOTTOLA FRANK Officer | -- | Direct | -- | Feb 21, 2025 |
| RUBIN JONATHAN Officer | -- | Direct | -- | Feb 21, 2025 |
| NEWHALL CHARLES W III Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| DEC TIMOTHY C Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| GEMAYEL GEORGES PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| HUDSON FREDERICK M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| BHATT PADMANABH P Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| BARLOW CARROLEE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| MOTTOLA FRANK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| RUBIN JONATHAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| SENSENIG BETHANY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 21, 2025 |
| RUBIN JONATHAN Officer | Sale at price 39.15 per share. | Direct | 36,292 | Feb 21, 2025 |
| BHATT PADMANABH P Officer | Conversion of Exercise of derivative security at price 29.61 per share. | Direct | 280,614 | Feb 4, 2025 |
| BHATT PADMANABH P Officer | Sale at price 39.70 per share. | Direct | 376,237 | Feb 4, 2025 |
| BHATT PADMANABH P Officer | Conversion of Exercise of derivative security at price 29.61 per share. | Direct | 96,914 | Jan 28, 2025 |
| BHATT PADMANABH P Officer | Sale at price 39.62 per share. | Direct | 129,676 | Jan 28, 2025 |
| HUDSON FREDERICK M Director | Conversion of Exercise of derivative security at price 9.13 per share. | Direct | 182,600 | Jan 22, 2025 |
| RUBIN JONATHAN Officer | -- | Direct | -- | Dec 27, 2024 |
| KHATTAR JACK A Chief Executive Officer | -- | Direct | -- | Dec 27, 2024 |
| BHATT PADMANABH P Officer | Conversion of Exercise of derivative security at price 23.99 - 25.30 per share. | Direct | 532,361 | Dec 3, 2024 |
| BHATT PADMANABH P Officer | Sale at price 36.68 per share. | Direct | 788,437 | Dec 3, 2024 |
| NEWHALL CHARLES W III Director | Conversion of Exercise of derivative security at price 9.13 per share. | Direct | 182,600 | Nov 11, 2024 |
| NEWHALL CHARLES W III Director | Sale at price 36.24 per share. | Direct | 387,768 | Nov 11, 2024 |
| KHATTAR JACK A Chief Executive Officer | Conversion of Exercise of derivative security at price 9.13 per share. | Direct | 1,141,250 | Nov 8, 2024 |
| GEMAYEL GEORGES PH.D. Director | Conversion of Exercise of derivative security at price 11.46 per share. | Direct | 123,619 | Nov 8, 2024 |
| KHATTAR JACK A Chief Executive Officer | Sale at price 36.29 per share. | Direct | 4,536,250 | Nov 8, 2024 |
| GEMAYEL GEORGES PH.D. Director | Sale at price 36.30 per share. | Direct | 391,568 | Nov 8, 2024 |
| HUDSON FREDERICK M Director | Sale at price 36.28 per share. | Direct | 316,434 | Nov 8, 2024 |
| MOTTOLA FRANK Officer | Conversion of Exercise of derivative security at price 9.13 per share. | Direct | 136,950 | Nov 7, 2024 |
| KHATTAR JACK A Chief Executive Officer | Conversion of Exercise of derivative security at price 9.13 per share. | Direct | 1,141,250 | Nov 7, 2024 |
| GEMAYEL GEORGES PH.D. Director | Conversion of Exercise of derivative security at price 11.46 per share. | Direct | 162,881 | Nov 7, 2024 |
| MOTTOLA FRANK Officer | Sale at price 36.98 per share. | Direct | 554,700 | Nov 7, 2024 |
| KHATTAR JACK A Chief Executive Officer | Sale at price 36.68 per share. | Direct | 4,585,000 | Nov 7, 2024 |
| GEMAYEL GEORGES PH.D. Director | Sale at price 36.62 per share. | Direct | 520,480 | Nov 7, 2024 |
| GEMAYEL GEORGES PH.D. Director | Conversion of Exercise of derivative security at price 11.46 per share. | Direct | 114,600 | Sep 13, 2024 |
| GEMAYEL GEORGES PH.D. Director | Sale at price 31.33 per share. | Direct | 435,048 | Sep 13, 2024 |
| KHATTAR JACK A Chief Executive Officer | -- | Direct | -- | Sep 3, 2024 |
| BHATT PADMANABH P Officer | -- | Direct | -- | Aug 20, 2024 |
| BHATT PADMANABH P Officer | Conversion of Exercise of derivative security at price 25.30 per share. | Direct | 366,622 | Mar 21, 2024 |
| BHATT PADMANABH P Officer | Sale at price 35.31 per share. | Direct | 511,677 | Mar 21, 2024 |
| BHATT PADMANABH P Officer | Conversion of Exercise of derivative security at price 25.30 per share. | Direct | 10,120 | Mar 20, 2024 |
| BHATT PADMANABH P Officer | Sale at price 35.31 per share. | Direct | 14,124 | Mar 20, 2024 |
| BHATT PADMANABH P Officer | Conversion of Exercise of derivative security at price 25.30 per share. | Direct | 312,809 | Mar 19, 2024 |
| BHATT PADMANABH P Officer | Sale at price 35.31 per share. | Direct | 436,573 | Mar 19, 2024 |
Related Tickers
COLL Collegium Pharmaceutical, Inc.
29.80
+0.81%
PCRX Pacira BioSciences, Inc.
23.40
-6.74%
IRWD Ironwood Pharmaceuticals, Inc.
0.6842
-6.76%
ANIK Anika Therapeutics, Inc.
12.41
+4.73%
ETON Eton Pharmaceuticals, Inc.
17.07
-1.61%
PBH Prestige Consumer Healthcare Inc.
86.97
-1.22%
PAHC Phibro Animal Health Corporation
24.60
+0.41%
AMPH Amphastar Pharmaceuticals, Inc.
23.88
-1.89%
UTHR United Therapeutics Corporation
308.07
-0.88%
INDV.L Indivior PLC
846.00
+0.06%